{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:41:39Z","timestamp":1792341699786,"version":"4.4.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["ZIAAA000550"],"award-info":[{"award-number":["ZIAAA000550"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["Y1AA-3009"],"award-info":[{"award-number":["Y1AA-3009"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neubiorev.2026.106990","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:10:06Z","timestamp":1789830606000},"page":"106990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Central nervous system effects of GLP-1 receptor agonists: A systematic review of human neuroimaging studies"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-3088","authenticated-orcid":false,"given":"Leyla R.","family":"Brucar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7175-5776","authenticated-orcid":false,"given":"Kylee B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/oby.23120","article-title":"Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic","volume":"29","author":"Acosta","year":"2021","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1471-4159.2004.02914.x","article-title":"The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem","volume":"92","author":"Alvarez","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2026.106990_bib4","article-title":"GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review","volume":"35","author":"Aoun","year":"2024","journal-title":"J. Clin. Transl. Endocrinol."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106990_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/14656566.2025.2517802","article-title":"Predicting treatment response to GLP-1 receptor agonists: still tossing the coin or doing better?","volume":"26","author":"Apostolopoulou","year":"2025","journal-title":"Expert. Opin. Pharmacother."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as Compared with Semaglutide for the Treatment of Obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"10103","key":"10.1016\/j.neubiorev.2026.106990_bib7","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2026.106990_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2024.11.019","article-title":"A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disorders","volume":"370","author":"Au","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4093\/dmj.2019.0018","article-title":"Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus","volume":"44","author":"Bae","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.neubiorev.2026.106990_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.121310","article-title":"The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses","author":"Ballum","year":"2026","journal-title":"J. Affect. Disord."},{"issue":"17","key":"10.1016\/j.neubiorev.2026.106990_bib11","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJMp2600300","article-title":"GLP-1 Receptor Agonists and Eating Disorders \u2014 Cause for Concern","volume":"394","author":"Banks","year":"2026","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/eat.24109","article-title":"Use of glucagon-like peptide-1 receptor agonists in eating disorder populations","volume":"57","author":"Bartel","year":"2024","journal-title":"Int. J. Eat. Disord."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106990_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3167","article-title":"Exenatide modulates visual cortex responses","volume":"35","author":"Binda","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"8065","key":"10.1016\/j.neubiorev.2026.106990_bib14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41586-025-08953-9","article-title":"The history and future of resting-state functional magnetic resonance imaging","volume":"641","author":"Biswal","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clinthera.2020.10.014","article-title":"The Neurobiology of Binge-Eating Disorder Differs from Obesity: Implications for Differential Therapeutics","volume":"43","author":"Boswell","year":"2021","journal-title":"Clin. Ther."},{"issue":"404","key":"10.1016\/j.neubiorev.2026.106990_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0972","article-title":"A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus","volume":"9","author":"Botfield","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2026.106990_bib17","unstructured":"Brain Expression Cluster (RNA): Glucagon like Peptide 1 Receptor (GLP1R). Accessed June 11, 2026. https:\/\/www.proteinatlas.org\/ENSG00000112164-GLP1R\/brain."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41398-025-03739-z","article-title":"Subtypes of cocaine use disorder and their neurobehavioral profiles","volume":"16","author":"Brucar","year":"2025","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106990_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.biopsych.2022.12.020","article-title":"Current Approaches in Computational Psychiatry for the Data-Driven Identification of Brain-Based Subtypes","volume":"93","author":"Brucar","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41398-025-03408-1","article-title":"Mechanism-based subtyping in binge eating: understanding neurobehavioral heterogeneity across negative emotionality, approach behavior, and executive function","volume":"15","author":"Brucar","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106990_bib21","first-page":"1","article-title":"Neurobiological subtypes in alcohol use disorder and their phenotypic and clinical profiles","author":"Brucar","year":"2026","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106990_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107312","article-title":"IUPHAR review \u2013 Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target","volume":"207","author":"Bruns VI","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry J. Am. Assoc. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00395-025-01096-y","article-title":"Exendin-4 improves cerebral ischemia by relaxing microvessels, rapidly increasing cerebral blood flow after reperfusion","volume":"120","author":"Chen","year":"2025","journal-title":"Basic. Res. Cardiol."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106990_bib25","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/dc21-2064","article-title":"Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study","volume":"45","author":"Cheng","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2026.106990_bib26","first-page":"1","article-title":"Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide","author":"Choi","year":"2025","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106990_bib27","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41366-023-01370-w","article-title":"A randomized controlled trial investigating the effect of liraglutide on self-reported liking and neural responses to food stimuli in participants with obesity","volume":"47","author":"Coppin","year":"2023","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/osp4.124","article-title":"The effect of the GLP-1 analogue Exenatide on functional connectivity within an NTS-based network in women with and without obesity","volume":"3","author":"Coveleskie","year":"2017","journal-title":"Obes. Sci. Pract."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.15277\/bjd.2023.418","article-title":"The factors predicting glucose and weight response to injectable semaglutide (Ozempic): real-world data from the Association of British Clinical Diabetologists\u2019 audit programme","volume":"23","author":"Crabtree","year":"2023","journal-title":"Br. J. Diabetes"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/bph.15683","article-title":"The role of glia in the physiology and pharmacology of glucagon-like peptide-1: implications for obesity, diabetes, neurodegeneration and glaucoma","volume":"179","author":"Cui","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106990_bib31","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.2337\/db14-1718","article-title":"Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System","volume":"64","author":"Daniele","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.neubiorev.2026.106990_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neubiorev.2021.07.020","article-title":"White matter integrity differences in obesity: A meta-analysis of diffusion tensor imaging studies","volume":"129","author":"Daoust","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10278","key":"10.1016\/j.neubiorev.2026.106990_bib33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11096-015-0219-8","article-title":"The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour","volume":"38","author":"de Boer","year":"2016","journal-title":"Int. J. Clin. Pharm."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106990_bib35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s44220-025-00390-x","article-title":"An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders","volume":"3","author":"De Giorgi","year":"2025","journal-title":"Nat. Ment. Health"},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106990_bib36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/brainsci11121647","article-title":"Brain Imaging of the GLP-1 Receptor in Obesity Using 68Ga-NODAGA-Exendin-4 PET","volume":"11","author":"Deden","year":"2021","journal-title":"Brain Sci."},{"issue":"14","key":"10.1016\/j.neubiorev.2026.106990_bib37","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J. Neurosci."},{"issue":"17","key":"10.1016\/j.neubiorev.2026.106990_bib38","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.3390\/ijms23179583","article-title":"Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases","volume":"23","author":"Diz-Chaves","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41398-023-02426-1","article-title":"Subtypes in addiction and their neurobehavioral profiles across three functional domains","volume":"13","author":"Drossel","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106990_bib40","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/dci24-0003","article-title":"Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity","volume":"47","author":"Drucker","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41591-025-04124-5","article-title":"The expanding landscape of GLP-1 medicines","volume":"32","author":"Drucker","year":"2026","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm.4246","article-title":"Resting-state connectivity biomarkers define neurophysiological subtypes of depression","volume":"23","author":"Drysdale","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41591-025-04106-7","article-title":"Liraglutide in mild to moderate Alzheimer\u2019s disease: a phase 2b clinical trial","volume":"32","author":"Edison","year":"2026","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106990_bib44","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2337\/dc15-2706","article-title":"Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects","volume":"39","author":"Eldor","year":"2016","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106990_bib45","article-title":"Glucagon-like peptide-1 medicines in neurological and psychiatric disorders","volume":"6","author":"Fang","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.neubiorev.2026.106990_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2025.4308","article-title":"Prospects of GLP-1 Therapies for Addiction and Mental Health Comorbidities\u2014Quo Vadis?: A Review","author":"Farokhnia","year":"2026","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106990_bib47","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106990_bib48","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.metabol.2016.03.009","article-title":"Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study","volume":"65","author":"Farr","year":"2016","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106990_bib49","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/dom.13827","article-title":"Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies","volume":"21","author":"Farr","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106990_bib50","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.tics.2019.03.009","article-title":"The Heterogeneity Problem: Approaches to Identify Psychiatric Subtypes","volume":"23","author":"Feczko","year":"2019","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neubiorev.2026.106990_bib51","article-title":"Effect of Tirzepatide on Alcohol Intake and Reward Processing in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder","author":"Fink-Jensen","year":"2026","journal-title":"Clin. Gov."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106990_bib52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2026.106990_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00555","article-title":"Brain Endothelial Cells Regulate Glucagon-Like Peptide 1 Entry Into the Brain via a Receptor-Mediated Process","volume":"11","author":"Fu","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neubiorev.2026.106990_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17718-y","article-title":"Blood-Brain Glucose Transfer in Alzheimer\u2019s disease: Effect of GLP-1 Analog Treatment","volume":"7","author":"Gejl","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2026.106990_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fnagi.2016.00108","article-title":"Alzheimer\u2019s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nec.2010.11.001","article-title":"Overview of Functional Magnetic Resonance Imaging","volume":"22","author":"Glover","year":"2011","journal-title":"Neurosurg. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106990_bib57","doi-asserted-by":"crossref","first-page":"341","DOI":"10.32598\/bcn.2021.2554.2","article-title":"Investigating the Glucagon-like Peptide-1 and Its Receptor in Human Brain: Distribution of Expression, Functional Implications, Age-related Changes and Species Specific Characteristics","volume":"14","author":"Gupta","year":"2023","journal-title":"Basic. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106990_bib58","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/oby.24027","article-title":"Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery","volume":"32","author":"Hall","year":"2024","journal-title":"Obesity"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106990_bib59","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s42255-023-00859-y","article-title":"Liraglutide restores impaired associative learning in individuals with obesity","volume":"5","author":"Hanssen","year":"2023","journal-title":"Nat. Metab."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial","volume":"82","author":"Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib61","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The Physiology of Glucagon-like Peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106990_bib63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide Once Weekly for the Treatment of Obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2026.106990_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104772","article-title":"Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent","volume":"138","author":"Jensen","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neubiorev.2026.106990_bib65","first-page":"dgaf278","article-title":"Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study","author":"Jensterle","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neubiorev.2026.106990_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01270","article-title":"Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"19","key":"10.1016\/j.neubiorev.2026.106990_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159863","article-title":"Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial","volume":"7","author":"Klausen","year":"2022","journal-title":"JCI Insight"},{"issue":"10540","key":"10.1016\/j.neubiorev.2026.106990_bib68","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(26)00305-3","article-title":"Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial","volume":"407","author":"Klausen","year":"2026","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bph.15677","article-title":"The role of glucagon-like peptide 1 (GLP-1) in addictive disorders","volume":"179","author":"Klausen","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib70","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/hbm.24998","article-title":"ENIGMA-DTI: Translating reproducible white matter deficits into personalized vulnerability metrics in cross-diagnostic psychiatric research","volume":"43","author":"Kochunov","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neubiorev.2026.106990_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2025.1638681","article-title":"Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational study","volume":"6","author":"Koide","year":"2025","journal-title":"Front. Clin. Diabetes Healthc."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106990_bib72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nn.4501","article-title":"Studying neuroanatomy using MRI","volume":"20","author":"Lerch","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106990_bib73","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.1111\/dom.70132","article-title":"Dapagliflozin restores odour-induced functional integration of primary olfactory cortex circuit but not olfactory-related regional brain activation in patients with type 2 diabetes: A 16-week randomised comparative study","volume":"27","author":"Li","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.neubiorev.2026.106990_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuroscience.2011.02.023","article-title":"Preproglucagon neurons project widely to autonomic control areas in the mouse brain","volume":"180","author":"Llewellyn-Smith","year":"2011","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106990_bib75","first-page":"43347","article-title":"PET\/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases","volume":"5","author":"Lu","year":"2015","journal-title":"Quant. Imaging Med. Surg."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib76","first-page":"7","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil. Med. Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib77","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/npp.2017.282","article-title":"Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes","volume":"43","author":"Mann","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2026.106990_bib78","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jad.2016.09.056","article-title":"Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study","volume":"207","author":"Mansur","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"7902","key":"10.1016\/j.neubiorev.2026.106990_bib79","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-022-04492-9","article-title":"Reproducible brain-wide association studies require thousands of individuals","volume":"603","author":"Marek","year":"2022","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106990_bib80","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1038\/s41591-025-03774-9","article-title":"Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial","volume":"31","author":"Martin","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2026.106990_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119438","article-title":"Advances in human intracranial electroencephalography research, guidelines and good practices","volume":"260","author":"Mercier","year":"2022","journal-title":"NeuroImage"},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106990_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr5051","article-title":"An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking","volume":"11","author":"Merkel","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41380-018-0017-5","article-title":"Depression and obesity: evidence of shared biological mechanisms","volume":"24","author":"Milaneschi","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"21","key":"10.1016\/j.neubiorev.2026.106990_bib84","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.3390\/ijms262110743","article-title":"GLP-1 and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential","volume":"26","author":"Moaket","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2026.106990_bib85","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106990_bib86","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/1567205016666190913155950","article-title":"A Pilot Study of Exenatide Actions in Alzheimer\u2019s Disease","volume":"16","author":"Mullins","year":"2019","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuroimage.2007.07.061","article-title":"Power calculation for group fMRI studies accounting for arbitrary design and temporal autocorrelation","volume":"39","author":"Mumford","year":"2008","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib88","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2016.10.001","article-title":"Glucagon-like Peptide-1 and the Central\/Peripheral Nervous System: Crosstalk in Diabetes","volume":"28","author":"Muscogiuri","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.neubiorev.2026.106990_bib89","first-page":"23","article-title":"Regulation of Glucose Homeostasis by GLP-1","volume":"121","author":"Nadkarni","year":"2014"},{"key":"10.1016\/j.neubiorev.2026.106990_bib90","unstructured":"National Institute of Health. Study Quality Assessment Tools | NHLBI, NIH. 2013. Accessed March 15, 2026. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s42003-019-0378-6","article-title":"fMRI replicability depends upon sufficient individual-level data","volume":"2","author":"Nee","year":"2019","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00395-021-00873-9","article-title":"Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke","volume":"116","author":"Nizari","year":"2021","journal-title":"Basic. Res. Cardiol."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106990_bib93","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1523\/JNEUROSCI.4920-04.2005","article-title":"Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Adult Hippocampus and Induces Progenitor Cell Proliferation","volume":"25","author":"Nyberg","year":"2005","journal-title":"J. Neurosci."},{"issue":"8077","key":"10.1016\/j.neubiorev.2026.106990_bib94","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41586-025-09250-1","article-title":"Longer scans boost prediction and cut costs in brain-wide association studies","volume":"644","author":"Ooi","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106990_bib95","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2026.106990_bib96","article-title":"Glucagon-like peptide 1 receptor agonists in substance use disorders: A systematic review of ClinicalTrials.Gov","volume":"23","author":"Patil","year":"2026","journal-title":"Addict. Behav. Rep."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106990_bib97","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/s41386-021-01051-0","article-title":"Identification of transdiagnostic psychiatric disorder subtypes using unsupervised learning","volume":"46","author":"Pelin","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00592-025-02611-2","article-title":"Muscle loss and GLP-1R agonists use","volume":"63","author":"Rossi","year":"2026","journal-title":"Acta Diabetol."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106990_bib99","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106990_bib100","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2337\/dc12-1925","article-title":"Exenatide-Induced Reduction in Energy Intake Is Associated With Increase in Hypothalamic Connectivity","volume":"36","author":"Schl\u00f6gl","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2026.106990_bib101","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cpr.2016.02.001","article-title":"Shared and unique mechanisms underlying binge eating disorder and addictive disorders","volume":"44","author":"Schulte","year":"2016","journal-title":"Clin. Psychol. Rev."},{"issue":"6482","key":"10.1016\/j.neubiorev.2026.106990_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sj\u00f6stedt","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib103","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-089477","article-title":"Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis","volume":"15","author":"Squire","year":"2025","journal-title":"BMJ Open."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106990_bib104","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hbm.20451","article-title":"Components of variance in a multicentre functional MRI study and implications for calculation of statistical power","volume":"29","author":"Suckling","year":"2007","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s40501-024-00331-y","article-title":"The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review","volume":"11","author":"Tempia Valenta","year":"2024","journal-title":"Curr. Treat. Options Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib106","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2337\/dc15-0772","article-title":"Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes","volume":"39","author":"ten Kulve","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2026.106990_bib107","doi-asserted-by":"crossref","unstructured":"ten Kulve J.S. ten, Veltman D.J., Bloemendaal L. van, et al. Endogenous GLP1 and GLP1 analogue alter CNS responses to palatable food consumption. Published online April 1, 2016. doi:10.1530\/JOE-15-0461.","DOI":"10.1530\/JOE-15-0461"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409238.2012.735642","article-title":"Striatocortical pathway dysfunction in addiction and obesity: differences and similarities","volume":"48","author":"Tomasi","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106990_bib109","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/s41591-024-03057-9","article-title":"Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety","volume":"30","author":"Tozzi","year":"2024","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41366-019-0348-6","article-title":"Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial","volume":"44","author":"Tronieri","year":"2020","journal-title":"Int. J. Obes."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106990_bib111","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans","volume":"63","author":"van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106990_bib112","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/oby.21200","article-title":"Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation","volume":"23","author":"van Bloemendaal","year":"2015","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106990_bib113","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/dom.12506","article-title":"Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans","volume":"17","author":"van Bloemendaal","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.neubiorev.2026.106990_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105667","article-title":"Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trial","volume":"137","author":"van Ruiten","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2026.106990_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.863592","article-title":"Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide","volume":"13","author":"van Ruiten","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106990_bib116","doi-asserted-by":"crossref","first-page":"e2590","DOI":"10.1210\/clinem\/dgac043","article-title":"Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes","volume":"107","author":"van Ruiten","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106990_bib117","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/dom.14732","article-title":"Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial","volume":"24","author":"van Ruiten","year":"2022","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib118","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/dom.15363","article-title":"Semaglutide, suicidal ideation and behaviour: A resting state functional magnetic resonance imaging perspective","volume":"26","author":"Verovnik","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.neubiorev.2026.106990_bib119","article-title":"Is the GLP-1 Receptor Agonist Semaglutide Able to Alleviate Mood in Patients With Major Depressive Disorder and Overweight or Obesity","author":"Vinberg","year":"2026","journal-title":"Clin. Gov."},{"key":"10.1016\/j.neubiorev.2026.106990_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2026.01.011","article-title":"GLP-1 Receptor Agonist Medications: Interactions With Addiction Neurocircuitry","author":"Volkow","year":"2026","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib121","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1467-789X.2012.01031.x","article-title":"Obesity and addiction: neurobiological overlaps","volume":"14","author":"Volkow","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.neubiorev.2026.106990_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2026.03.1002","article-title":"Glucagon-Like Peptide-1 Receptor Agonists in Psychiatry: A Pharmacoepidemiological Scoping Review","author":"Volkow","year":"2026","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106990_bib123","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2018.08.006","article-title":"Neural correlates of liraglutide effects in persons at risk for Alzheimer\u2019s disease","volume":"356","author":"Watson","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106990_bib124","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/oby.23673","article-title":"Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight\/obesity: STEP 5","volume":"31","author":"Wharton","year":"2023","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106990_bib125","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.neubiorev.2026.106990_bib126","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151800","article-title":"A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia","volume":"131","author":"Winzeler","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2026.106990_bib127","article-title":"Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: A Pilot Mechanistic Study","author":"Yammine","year":"2026","journal-title":"Clin. Gov."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106990_bib128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmet.2021.01.015","article-title":"The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell. Metab."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106990_bib129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s44220-023-00019-x","article-title":"Biological subtyping of psychiatric syndromes as a pathway for advances in drug discovery and personalized medicine","volume":"1","author":"Zhang","year":"2023","journal-title":"Nat. Ment. Health"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106990_bib130","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2337\/dc18-2584","article-title":"Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies","volume":"42","author":"Zhang","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2026.106990_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neubiorev.2026.106990_bib132","doi-asserted-by":"crossref","DOI":"10.1017\/neu.2025.6","article-title":"A systematic review on the role of glucagon-like peptide-1 receptor agonists on alcohol-related behaviors: potential therapeutic strategy for alcohol use disorder","volume":"37","author":"Zheng","year":"2025","journal-title":"Acta Neuropsychiatr."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106990_bib133","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426004471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426004471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:04:07Z","timestamp":1792339447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763426004471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":133,"alternative-id":["S0149763426004471"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106990","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central nervous system effects of GLP-1 receptor agonists: A systematic review of human neuroimaging studies","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106990"}}